Genomic cfDNA profiling feasible in metastatic CRPC

Comprehensive genomic profiling of cell-free DNA can provide clinically useful information in men with castration-resistant prostate cancer treated with enzalutamide, research indicates.
Source: MedWire News - Category: Consumer Health News Tags: Prostate cancer Source Type: news